| Literature DB >> 21829745 |
Marianne Lebbad1, Ingvor Petersson, Lillemor Karlsson, Silvia Botero-Kleiven, Jan O Andersson, Bo Svenungsson, Staffan G Svärd.
Abstract
BACKGROUND: Giardia intestinalis is one of the most common diarrhea-related parasites in humans, where infection ranges from asymptomatic to acute or chronic disease. G. intestinalis consists of eight genetically distinct genotypes or assemblages, designated A-H, and assemblages A and B can infect humans. Giardiasis has been classified as a possible zoonotic disease but the role of animals in human disease transmission still needs to be proven. We tried to link different assemblages and sub-assemblages of G. intestinalis isolates from Swedish human patients to clinical symptoms and zoonotic transmission. METHODOLOGY/PRINCIPALEntities:
Mesh:
Substances:
Year: 2011 PMID: 21829745 PMCID: PMC3149019 DOI: 10.1371/journal.pntd.0001262
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Distribution of assemblages among 207 isolates determined by PCR-RFLP and assemblage A- and B-specific PCR.
| Assemblages | |||||
| A | B | A+B | Not amplified | Total positive | |
| ß-giardin RFLP | 74 | 124 | 2 | 14 | 200 |
|
| 73 | 129 | 0 | 12 | 202 |
|
| 72 | 124 | 2 | 16 | 198 |
|
| 70 | 122 | 6 | 16 | 198 |
| Combined results | 73 | 128 | 6 | 7 | 207 |
Including three samples with a novel A pattern (Sweh166, 173, and 178).
Including one sample with a novel B pattern (Sweh198).
Including three samples with AI (Sweh166, 173, and 178) and 70 with AII patterns.
Including two samples with novel B patterns (Sweh121 and 154).
Molecular characterization of isolates from patients presenting with mixed assemblage A and B infections.
| Isolate | ß-giardin |
|
|
| Origin of infection | Co-infections | Patient information |
| Sweh068 | B | B | B | A | Ethiopia |
| Adoptive child |
| Sweh098 | A3 | AII | AII | A+B | India |
| Adult tourist |
| Sweh110 | A+B | A+B | B | A | India |
| Adult tourist |
| Sweh131 | A2 | A+B | AII | A+B | China | None | Adoptive child |
| Sweh140 | A3 | AII | AII | A+B | India |
| Adult tourist |
| Sweh207 | A+B | B | B | A | India |
| Adult tourist |
Data based on RFLP and sequencing.
Sequences containing overlapping nucleotides.
Confirmed by sequencing.
Figure 1PCR-RFLP analysis of Giardia isolates.
Panel A: Gelred (Biotium) stained 3.5% MetaPhor agarose gel (Cambrex) showing electrophoretic separation of nested β-giardin PCR products (511 bp) after digestion with HaeIII: lane 1, assemblage A (novel pattern Sweh166, 173, 178); lane 2, assemblage A (ordinary pattern); lane 3, assemblage B (ordinary pattern), lane 4, assemblage B (novel pattern Sweh198); lane 5, assemblage B (mixed pattern). Panel B: Electrophoretic separation of nested tpi PCR products (530 bp) after digestion with DdeI: lane 1, assemblage A; lane 2, assemblage B (ordinary pattern); lane 3, assemblage B (novel pattern Sweh121), lane 4, assemblage B (novel pattern Sweh154); lanes 5, 6 and 7, assemblage B (mixed patterns). Panel C: Electrophoretic separation of semi-nested gdh PCR products (432 bp) after digestion with NlaIV: lane 1, assemblage AII; lane 2, assemblage AI; lanes 3 and 4, assemblage B; lanes 5 and 6, assemblage B (mixed patterns). Molecular size markers (M) are 50-bp ladders (Invitrogen).
Characterization of 67 assemblage A isolates* based on sequencing data and assemblage-specific PCR.
| No. of isolates (isolate code) | ß-giardin |
|
|
| MLG |
| 31 | A2 | AII | AII | A | AII-1 |
| 1 (Sweh037) | A2 | AII | AII | A | Mixed |
| 1 (Sweh038) | A2 | AII | AII | A | AII novel |
| 26 | A3 | AII | AII | A | AII-2 |
| 5 | A2+A3 | AII | AII | A | Mixed AII-1+AII-2 |
| 2 (Sweh166, 178) | A | A | AI | A | A novel |
| 1 (Sweh173) | A | A | A | A | A novel |
*Isolates with mixed assemblage A+B infections are not included.
A/G at position 445.
GenBank acc. no. EU041753 (isolate ISSGd85, human).
C/T at position 460 and 468.
GenBank acc. no. AY655702 (unnamed isolate, cattle).
GenBank acc. no. EU781027 (isolate Swecat170, cat).
GenBank acc. no. EU769224 (isolate Swecat202, cat).
Equal to previous MLG from various Swedish animals (cats and ruminants).
Equal to previous MLG from Swefd154 (fallow deer) and Swecat202 (cat).
Figure 2Nucleotide maximum likelihood trees based on concatenated datasets for ß-giardin, gdh, and tpi gene sequences.
MLGs with unambiguous sequences identified in this study (Table 3 and 4) are combined with reference isolates and isolates from our previous MLG study of animals in Sweden [20] (Supplementary Table S1). (A) Phylogenetic tree based on 1884 aligned positions of assemblage A isolates. Isolates identified in the present study are indicated in red. (B) Phylogenetic tree based on 1358 aligned positions of 17 assemblage B MLGs identified in our present and our previous study [20]. BIII (red) and BIV (blue) isolates are assigned according to their clustering with reference isolates in phylogenetic trees of the individual genes (Fig. S1). Only bootstrap support values >50% are shown.
Characterization of 31 assemblage B isolates based on the ß-giardin, gdh, and tpi gene sequences*.
| Isolate | Isolate/Subtype/GenBank accession number | MLG | Intestinal symptoms | Origin of infection | ||
| ß-giardin |
|
| ||||
| Sweh001Sweh021, 022 | B1-3EU881698 | Ad-19/BIVAF069560 | Ad-7/BIVL40508 | 1 | NoYes, YesYesYes, No, No, NoYesYes, NoYesYes | SwitzerlandSweden, Malta |
| Sweh059 | B1-3 | Ad-19/BIV | gd-ber12, DQ923581 | 2 | Yes | Finland |
| Sweh144 | B1-3 | GS/M/BIV/L02116 | gd-ber12 | 3 | Yes | Sweden |
| Sweh158Sweh199, 200, 202 | B1-1EU637579 | Novel BHM140723 | Ad-7/BIV | 4 | YesYes, No, No | USASweden |
| Sweh168 | B1-1 | Ad-19/BIV | gd-ber12 | 5 | Yes | Sweden |
| Sweh154 | B1-1 | M12/BIV EU834845 | gd-ber12 | 6 | Yes | Sweden |
| Sweh074 | B1-1 | Ad-19/BIV | Ad-7/BIV | 7 | Yes | Mauritius |
| Sweh179 | B1-1 | GS/M BIV | Vanc89/UBC/059AY178750 | 8 | Yes | Nicaragua |
| Sweh033 | B1-2EU881697 | ST25DQ789114 | Vanc89/UBC/059BIV | 9 | Yes | Canada |
| Sweh192 | B1-5EU881700 | Ad-19/BIV | gd-ber12 | 10 | Yes | Sweden |
| Sweh047, 048, 049 | B1-5 | GS/M/BIV | gd-ber12 | 11 | Yes, Yes, No | Sweden |
| Sweh060 | BG-Ber6 DQ090527 | 2434AY368165 | Novel BHM136881 | 12 | Yes | Sweden |
| Sweh136 | ISSGF4/B4 AY072728 | BAH12/BIII AF069561 | Novel BHM136884 | 13 | Yes | Germany |
| Sweh107 | Novel B HM165222 | Novel BHM140716 | BAH12/BIII AF069059 | 14 | Yes | India |
*The sequences contained no ambiguous positions at any loci. Identical sequences are marked in the same color.
Family cluster.
Country of infection for index case.
Probable area of origin of infection in 214 giardiasis patients presented in relation to assemblages.
| Sweden | Other European countries | Africa | Asia | Latin America | North America | Not stated | Total | |
| Assemblage A | 22 | 5 | 11 | 22 | 12 | 0 | 1 | 73 |
| Assemblage B | 42 | 11 | 20 | 43 | 9 | 3 | 0 | 128 |
| Assemblage A+B | 0 | 0 | 1 | 5 | 0 | 0 | 6 | |
| PCR negative | 2 | 0 | 3 | 1 | 1 | 0 | 0 | 7 |
| All cases | 66 | 16 | 35 | 71 | 22 | 3 | 1 | 214 |
Thirty-eight infections originating from Asia were acquired in India, and six of those were assemblage A, 28 assemblage B, and four assemblage A+B.
Symptoms of 145 giardiasis patients in relation to assemblage (mixed infections with other enteropathogens excluded).*
| Patients infected with | |||
| Symptoms | Assemblage A (n = 51) | Assemblage B (n = 87) | All patients (n = 145 |
| Diarrhea | 48/51 (94) | 86/87 (99) | 141/145 (97) |
| Bowel movements | |||
| <3/day | 9/51 (18) | 20/87 (23) | 30/145 (21) |
| 3–5/day | 12/51 (24) | 31/87 (36) | 44/145 (30) |
| >5/day | 27/51 (53) | 35/87 (40) | 67/145 (46) |
| Abdominal pain | 33/50 (66) | 55/85 (65) | 94/142 (66) |
| Bloody stools | 3/50 (6) | 5/87 (6) | 8/144 (6) |
| Vomiting | 17/50 (34) | 29/87 (33) | 47/144 (33) |
| Flatulence | 33/51 (65) | 73/86 (85) | 112/144 (78) |
| Fever >38°C | 12/50 (24) | 19/85 (22) | 32/142 (23) |
| Loss of weight | 33/50 (66) | 65/85 (76) | 103/142 (73) |
NOTE: Response rates for the different items on the questionnaires varied from 98% to 100%.
*The data given represent number of findings/number of patients who answered the specific questions (%).
No significant difference between the assemblage A and B patient groups.
Significant difference between the assemblage A and assemblage B patient groups, p = 0.006.
Includes four patients with assemblage A+B and three with negative PCR results.